Vivos Therapeutics VVOS
NASDAQ VVOS
$0.28 +0.00 (+1.79%)
At close: Aug 20, 2026 · 1:15 PM UTC

Vivos Therapeutics (VVOS) EBIT Growth (5y) (2025 - 2026)

Vivos Therapeutics (VVOS) EBIT Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn
10 Vivos Therapeutics 4.93 Mn 3.13 Mn 2.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.20%
Dec 31, 2025 -0.43%
Sep 30, 2025 -21.11%
Jun 30, 2025 -27.97%
Mar 31, 2025 -8.90%